Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter

Oncogene volume 19, pages 6229–6239 (2000)Cite this article

Abstract

Gene expression can be manipulated by the introduction of a hybrid gene formed by linking a highly tissue-specific regulatory element to a gene whose expression might be expected to alter cellular function. Previously, we have shown that the human FGF1 gene contains four distinct tissue-specific promoters. In an effort to perturb the programming of proliferation and differentiation in a subset of neural cells, we have produced transgenic mice bearing the brain-specific promoter of the human FGF1 gene joined to the SV40 immediate early gene, which encodes the large T antigen. The resulting mice, and offspring from four individual lines, developed brain tumors that originated in the pontine gray, just rostral to the fourth ventricle. Tumors were moderately vascularized, as demonstrated by staining with both hematoxylin and eosin and antibodies to three different endothelial cell markers, but vessels were histologically normal. Scattered tumor foci were present as early as postnatal day 26; and affected animals died between 5–8 months of age. In mature animals, tumors lacked terminal differentiation markers for astrocytes (glial fibrillary acidic protein) or neurons (synaptophysin and neuron-specific enolase). However, they expressed high levels of proliferating cell nuclear antigen and vimentin, markers for proliferating cells. This immunophenotype is consistent with the tumor being at an early stage of differentiation. Therefore, these mice may provide a valuable tool for the study of tumorigenesis, replenishment and differentiation of neural stem cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Alam KY, Frostholm A, Hackshaw KV, Evans JE, Rotter A and Chiu I-M. . 1996 J. Biol. Chem. 271: 30263–30271.

  • Anderson DJ. . 1999 Curr. Opin. Neurobiol. 9: 517–524.

  • Barres BA. . 1999 Cell 97: 667–670.

  • Bergers G, Javaherian K, Lo K-M, Folkman J and Hanahan D. . 1999 Science 284: 808–812.

  • Black DL. . 1998 Neuron 20: 165–168.

  • Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID and McKay RDG. . 1999 Science 285: 754–756.

  • Chiu I-M, Wang W-P and Lehtoma K. . 1990 Oncogene 5: 755–762.

  • Cho JY, Xing S, Liu X, Buckwalter TLF, Hwa L, Sferra TJ, Chiu I-M and Jhiang SM. . 2000 Hum. Gene Thera. 7: 740–749.

  • Chotani MA and Chiu I-M. . 1997 Cell Growth Differ. 8: 9999–10013.

  • Davis AA and Temple S. . 1994 Nature 372: 263–266.

  • Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM and Alvarez-Buylla A. . 1999 Cell 97: 703–716.

  • Eckenstein FP, Kuzis K, Nishi R, Woodward WR, Meshul C, Sherman L and Ciment G. . 1994 Biochem Pharmacol. 47: 103–110.

  • Eng LF and Ghirnikar RS. . 1994 Brain Pathol. 4: 229–237.

  • Fearon ER and Vogelstein B. . 1990 Cell 61: 759–767.

  • Frisen J, Johansson CB, Torok C, Risling M and Lendahl U. . 1995 J. Cell Biol. 131: 453–464.

  • Fung KM, Chikaraishi DM, Suri C, Theuring F, Messing A, Albert DM, Lee VM & Trojanowski JQ. . 1994 Lab. Invest. 70: 114–124.

  • Fung KM and Trojanowski JQ. . 1995 J. Neuropathol. Exp. Neurol. 54: 285–296.

  • Hanahan D. . 1985 Nature 315: 115–122.

  • Hanahan D and Folkman J. . 1996 Cell 86: 353–364.

  • Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U and Frisén J. . 1999 Cell 96: 25–34.

  • Liu Y, Ray SK, Yang X-Q, Luntz-Leybman V and Chiu I-M. . 1998 J. Biol. Chem. 273: 19269–19276.

  • Madiai F, Hackshaw KV and Chiu I-M. . 1999 J. Biol. Chem. 274: 11937–11944.

  • McKeehan WL, Wang F and Kan M. . 1998 Prog. Nucleic Acid Res. Mol. Biol. 59: 135–176.

  • Mehta VB, Connors L, Wang H-C, Chiu I-M. . 1998 J. Biol. Chem. 273: 4197–4205.

  • Messing A, Chen HY, Palmiter RD and Brinster RL. . 1985 Nature 316: 461–463.

  • Mignatti P, Morimoto T and Rifkin DB. . 1992 J. Cell. Physiol. 151: 81–93.

  • Myers RL, Payson RA, Chotani MA, Deaven LL and Chiu I-M. . 1993 Oncogene 8: 341–349.

  • Myers RL, Chedid M, Tronick SR and Chiu I-M. . 1995a Oncogene 11: 785–789.

  • Myers RL, Ray SK, Eldridge R, Chotani MA and Chiu I-M. . 1995b J. Biol. Chem. 270: 8257–8266.

  • Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G and Goldfarb M. . 1996 J. Biol. Chem. 271: 15292–15297.

  • Ornitz DM. . 2000 Bioessays 22: 108–112.

  • Palmiter RD, Chen HY, Messing A and Brinster RL. . 1985 Nature 316: 457–460.

  • Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH and Frisen J. . 1999 J. Cell Biol. 145: 503–514.

  • Ray SK, Yang X-Q and Chiu I-M. . 1997 J. Biol. Chem. 272: 7546–7555.

  • Reifenberger G, Szymas J and Wechsler W. . 1987 Acta Neuropathol. 74: 105–123.

  • Risau W. . 1997 Nature 386: 671–674.

  • Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T and van Dyke T. . 1994 Cell 78: 703–711.

  • Taber-Pierce E. . 1966 J. Comp. Neurol. 126: 219–240.

  • Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J and Ezekowitz RA. . 1994 J. Clin. Invest. 93: 2357–2364.

  • Tarantini F, LaVallee T, Jackson A, Gamble S, Carreira CM, Garfinkel S, Burgess WH and Maciag T. . 1998 J. Biol. Chem. 273: 22209–22216.

  • Temple S and Alvarez-Buylla A. . 1999 Curr. Opin. Neurobiol. 9: 135–141.

  • Tooze J. . 1981 Molecular Biology of Tumor Viruses Pt. 2, ed. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).

  • Yachnis AT, Rorke LB and Trojanowski JQ. . 1994 J. Neuropathol Exp. Neurol. 53: 61–71.

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, Ohio, USA

    Ing-Ming Chiu, Kathy Touhalisky & Yang Liu

  2. Department of Pathology, The Ohio State University, Columbus, OH 43210, Ohio, USA

    Allan Yates

  3. Department of Pharmacology, The Ohio State University, Columbus, OH 43210, Ohio, USA

    Adrienne Frostholm

Authors
  1. Ing-Ming Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathy Touhalisky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Allan Yates
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adrienne Frostholm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiu, IM., Touhalisky, K., Liu, Y. et al. Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter. Oncogene 19, 6229–6239 (2000). https://doi.org/10.1038/sj.onc.1204021

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204021

Keywords

This article is cited by

Search

Advanced search

Quick links